Management of early breast cancer in older women: from screening to treatment

References

• Binder-FoucardFBossardNDelafossePBelotAWoronoffASRemontetLIncidence and mortality of cancer in France during the period 1980–2012: solid tumorsJ Epidemiol Publ Health201362295108
   Web of Science ®Google Scholar
• YancikRRiesLACancer in older persons: an international issue in an aging worldSemin Oncol200431212813615112144
   PubMed Web of Science ®Google Scholar
• JemalACleggLXWardEAnnual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survivalCancer2004101132715221985
   PubMed Web of Science ®Google Scholar
• RiesLAGEisnerMPKosaryCLSEER Cancer Statistics Review. 1973–1999Bethesda, MDNational Cancer Institute2009
   Google Scholar
• WalterLCSchonbergMAScreening mammography in older women: a reviewJAMA2014311131336134724691609
   PubMed Web of Science ®Google Scholar
• MarmotMGAltmanDGCameronDAThe benefits and harms of breast cancer screening: an independent reviewBr J Cancer2013108112205224023744281
   PubMed Web of Science ®Google Scholar
• DiabSGElledgeRMClarkGMTumor characteristics and clinical outcome of elderly women with breast cancerJ Natl Cancer Inst20009255055610749910
   PubMed Web of Science ®Google Scholar
• BergJWHutterRVBreast cancerCancer199575S12572698001000
   PubMedGoogle Scholar
• MonfardiniSFerrucciLFratinoLDel LungoISerrainoDZagonelVValidation of a multidimensional evaluation scale for use in elderly cancer patientsCancer1996773954018625250
   PubMed Web of Science ®Google Scholar
• AudisioRAWyldLNo standard is set for older women with breast cancerEur J Surg Oncol20154160760925725950
   PubMed Web of Science ®Google Scholar
• KiderlenMBastiaannetEWalshPMSurgical treatment of early stage breast cancer in elderly: an international comparisonBreast Cancer Res Treat2012132267568222119939
   PubMed Web of Science ®Google Scholar
• RobertsonJFToddJHEllisIOElstonCWBlameyRWComparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancerBMJ19882975115143139179
   PubMedGoogle Scholar
• GazetJCFordHTCoombesRCProspective randomized trial of tamoxifen vs surgery in elderly patients with breast cancerEur J Surg Oncol1994202072148181594
   PubMedGoogle Scholar
• FentimanISChristiaensMRParidaensREORTC treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomyEur J Cancer20033930931612565982
   PubMed Web of Science ®Google Scholar
• MustacchiGCeccheriniRMilaniSItalian Cooperative Group GRETATamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trialAnn Oncol20031441442012598347
   PubMed Web of Science ®Google Scholar
• BatesTRileyDLHoughtonJFallowfieldLBaumMBreast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working PartyBr J Surg1991785915942059815
   PubMed Web of Science ®Google Scholar
• HindDWyldLReedMSurgery vs tamoxifen for operable primary breast cancer in older women: cochrane reviewBr J Cancer2007961025102917285133
   PubMed Web of Science ®Google Scholar
• BiganzoliLWildiersHOakmanCManagement of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)Lancet Oncol201213e148e16022469125
   PubMed Web of Science ®Google Scholar
• WillsherPCRobertsonJFRJacksonLAl-HilalyMBlarneyRWInvestigation of primary tamoxifen therapy for elderly patients with operable breast cancerBreast19976150154
   Web of Science ®Google Scholar
• FennesseyMBatesTMcRaeKRileyDHoughtonJBaumMRandomised trial of surgery plus tamoxifen vs tamoxifen-alone in women over age 70 with operable breast cancerBr J Surg20049169970415164437
   PubMed Web of Science ®Google Scholar
• CapassoINuzzoFLaboniaVLandiGRossiEDe MatteisASurgery and tamoxifen vs tamoxifen as treatment of stage I and II breast cancer in over to 70 years old women: ten years follow-upAnn Oncol20001120
   Web of Science ®Google Scholar
• FisherBBauerMWickerhamDRedmondCKFisherERRelation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP updateCancer198352155115576352003
   PubMed Web of Science ®Google Scholar
• MartelliGMiceliRDaidoneMGAxillary dissection versus no axillary dissection in elderly patients with breast cancer and no palpable axillary nodes: results after 15 years of follow-upAnn Surg Oncol20111812513320652755
   PubMed Web of Science ®Google Scholar
• ArmandoEGiulianoMDKellyKAxillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trialJAMA2011305656957521304082
   PubMed Web of Science ®Google Scholar
• PetrekJAHeelanMCIncidence of breast carcinoma-related lymphedemaCancer199883277627819874397
   PubMed Web of Science ®Google Scholar
• HallSJBrownSEPorterGRJAxillary ultrasound in staging breast cancer: diagnostic accuracy and effect on subsequent axillary surgery – the Plymouth experienceBreast Cancer Res200911Suppl 221
   Google Scholar
• SyedAGarbosMPatelABradpieceHStephanieJRole of axillary ultrasound in defining surgical management of breast cancer patients with nodal diseaseCancer Res20096924 Suppl
   Web of Science ®Google Scholar
• Early Breast Cancer Trialists Collaborative Group (EBCTCG)Polychemotherapy for early breast cancer: an overview of the randomised trialsLancet19983529309429752815
   PubMed Web of Science ®Google Scholar
• BiganzoliLGoldhirshAStraehleCAdjuvant chemotherapy in elderly patients with breast cancer: a survey of the Breast International Group (BIG)Ann Oncol200415220721014760110
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trialsLancet2008371294018177773
   PubMed Web of Science ®Google Scholar
• GiordanoSHDuanZKuoYFUse and outcomes of adjuvant chemotherapy in older women with breast cancerJ Clin Oncol2006242750275616782915
   PubMed Web of Science ®Google Scholar
• ElkinEBHurriaAMitraNAdjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohortJ Clin Oncol2006242757276416782916
   PubMed Web of Science ®Google Scholar
• MussHBBerryDConstanceTAdjuvant chemotherapy in older women with early-stage breast cancerN Engl J Med2009360202055206519439741
   PubMed Web of Science ®Google Scholar
• JagerAVerweijJSleijferSAdjuvant chemotherapy in older patients with breast cancerNat Rev Clin Oncol200961056356519786999
   PubMed Web of Science ®Google Scholar
• KunklerIRadiotherapy issues in elderly breast cancer patientsBreast Care (Basel)20127645345924715826
   PubMed Web of Science ®Google Scholar
• HughesKSSchnaperLABellonJRLumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343J Clin Oncol2013312382238723690420
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)Tamoxifen for early breast cancer: an overview of the randomized trialsLancet1998351145114689605801
   PubMed Web of Science ®Google Scholar
• CastiglioneMGelberRDGoldhirshAAdjuvant systemic therapy for breast cancer in the elderly: competing causes of mortalityJ Clin Oncol1990835195262407812
   PubMed Web of Science ®Google Scholar
• CummingsFJGrayDCTormeyTEAdjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of deathJ Clin Oncol199311129358418238
   PubMed Web of Science ®Google Scholar
• MouridsenHTAndersenAPBrinckerHAdjuvant tamoxifen in post-memopausal high risk breast cancer patients: present status of Danish breast cancer cooperative group trialsNCI Monogr198511151183534583
   PubMedGoogle Scholar
• CrivellariDPriceKRichardDAdjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVJ Clin Oncol2003214517452314673038
   PubMed Web of Science ®Google Scholar
• The Breast International Group (BIG) 1-98 Collaborative GroupA comparison of letrozole and tamoxifen in postmenopausal women with early breast cancerN Engl J Med20053532747275716382061
   PubMed Web of Science ®Google Scholar
• BaumMBuzdarACuzickJAnastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial efficacy and safety update analysesCancer2003981802181014584060
   PubMed Web of Science ®Google Scholar
• BrunelloAMonfardiniSCrivellariDMulticenter analysis of activity and safety of trastuzumab plus chemotherapy in advanced breast cancer in elderly women (>70 years)J Clin Oncol20082615 Abstract 1096
   Web of Science ®Google Scholar
• PatonVEKleinPLiebermanGTrastuzumab (H) benefits both younger and older women with HER2 positive MBCProc Am Soc Clin Oncol200322 Abstract 294
   Google Scholar
• FyfeGAMassRMurphyMSurvival benefit of trastuzumab (Herceptin) and chemotherapy in older (age >60) patientsProc Am Soc Clin Oncol200120 Abstract 189
   Google Scholar
• SerranoCCortésJDe Mattos-ArrudaLTrastuzumab related cardiotoxicityin the elderly: a role for cardiovascular risk factorsAnn Oncol20122389790221828361
   PubMed Web of Science ®Google Scholar
• Chavez-MacGregorMZhangNBuchholzTATrastuzumab-related cardiotoxicity among older patients with breast cancerJ Clin Oncol20133134222422824127446
   PubMedGoogle Scholar